Anita J Campbell
Overview
Explore the profile of Anita J Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kollmann T, Amenyogbe N, Schaltz-Buchholzer F, Baek O, Campbell J, Lynn D, et al.
J Infect Dis
. 2025 Feb;
PMID: 39913242
Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb) and is the leading cause of death. Bacillus Calmette-Guérin (BCG) is the only licensed TB vaccine. Preclinical studies have shown that in...
2.
Anpalagan K, Bowen A, Lamborn L, Roebuck D, Carter T, Cannon J, et al.
Infect Dis Now
. 2024 Nov;
55(1):105010.
PMID: 39542423
Introduction: Staphylococcus aureus bacteraemia (SAB) is the most common cause of sepsis, contributing to paediatric intensive care unit admission in Australia and New Zealand. While deep venous thrombosis (DVT) has...
3.
Tio S, Chen S, Heath C, Pradhan A, Morris A, Korman T, et al.
Open Forum Infect Dis
. 2024 Nov;
11(11):ofae594.
PMID: 39494451
Background: International consensus definitions for invasive aspergillosis (IA) in research are rigorous, yet clinically significant cases are often excluded from clinical studies for not meeting proven/probable IA case definitions. To...
4.
Williams A, Coombs G, Bell J, Daley D, Mowlaboccus S, Bryant P, et al.
J Pediatric Infect Dis Soc
. 2024 Oct;
14(2).
PMID: 39468748
Background: Rising proportions of antimicrobial resistance (AMR) have been observed in both Staphylococcus aureus and Enterococcus spp. isolates. Methods: The Australian Group on Antimicrobial Resistance surveillance program captures clinical and...
5.
Williams A, Coombs G, Bell J, Daley D, Mowlaboccus S, Bryant P, et al.
J Pediatric Infect Dis Soc
. 2024 Oct;
13(12):617-625.
PMID: 39460715
Background: Gram-negative bloodstream infections are associated with significant morbidity and mortality in children. Increasing antimicrobial resistance (AMR) is reported globally, yet efforts to track pediatric AMR at a national level...
6.
Campbell A, Russell F, Marais B, Britton P, Bowen A, Blyth C, et al.
Lancet Reg Health West Pac
. 2024 Sep;
51:101205.
PMID: 39328247
No abstract available.
7.
Williams A, Coombs G, Bell J, Daley D, Mowlaboccus S, Bryant P, et al.
Commun Dis Intell (2018)
. 2024 Aug;
48.
PMID: 39165021
From 1 January 2020 to 31 December 2021, thirty-eight institutions across Australia submitted data to the Australian Group on Antimicrobial Resistance (AGAR) from patients aged < 18 years (AGAR-Kids). Over...
8.
Campbell A, Anpalagan K, Best E, Britton P, Gwee A, Hatcher J, et al.
JAMA Pediatr
. 2024 Aug;
178(10):1066-1071.
PMID: 39158898
Importance: There is a recognized unmet need for clinical trials to provide evidence-informed care for infants, children and adolescents. This Special Communication outlines the capacity of 3 distinct trial design...
9.
MacKay C, Kuthubutheen J, Campbell A
Curr Opin Infect Dis
. 2024 Mar;
37(3):220-225.
PMID: 38545833
Purpose Of Review: With cochlear implantation becoming increasingly performed worldwide, an understanding of the risk factors, preventive measures, and management of cochlear implant (CI) infection remains important given the significant...
10.
Tio S, Chen S, Hamilton K, Heath C, Pradhan A, Morris A, et al.
Lancet Reg Health West Pac
. 2023 Sep;
40:100888.
PMID: 37701716
Background: New and emerging risks for invasive aspergillosis (IA) bring the need for contemporary analyses of the epidemiology and outcomes of IA, in order to improve clinical practice. Methods: The...